Excerpts

For example, in a UK study, no change in incidence trends during 1997–2017 was observed for ankle, foot, wrist, and hand sites, while OA at the knee and hip showed a slightly increasing trend [ 17 ].

Haematological Parameters A comparison of the haemoglobin concentration, platelet count, and fibrinogen concentration between the pre-ECMO status and Day 0 revealed highly significant reductions in all three variables.

Among these are patients with acute myocardial infarction (MI) with CS [ 6 ], while several studies have shown a decreasing trend in mortality among patients with CS [ 6 , 7 , 8 , 9 , 10 ].

All of these variables showed a trend towards improvement at the 1-year time point, but this improvement was significantly greater for ambulatory than for hospitalized patients.

An increasing trend as treatment progressed in both the prevalence and severity of depression was noted across most studies; this trend generally reversed and declined post-treatment [ 16 , 27 , 28 , 47 ].

Concerning the quality of reporting of these RCTs has resulted in an improvement of the MCMS score registering a positive trend across the analyzed set.

As mentioned earlier, STRIDE-II advocates the avoidance of structural destruction and dysfunction of the intestinal tract, and improvement of physical function and QOL or ADL as long-term therapeutic goals for patients with IBD, so nutritional intervention in patients with IBD and sarcopenia is highly significant [ 16 ].

In terms of clinical outcomes, the optimal recovery showed an increasing trend in the 2nd quintile and started to plateau after the third quintile.

However, on univariate binary logistic regression, none of those variables was close to significance to enter in a model predicting all-cause mortality. 3.4.

Importantly, obesity is also associated with alterations in the gut microbiota and is another highly significant risk factor in COVID-19.

Subsequent univariate analysis for Shame yielded a significant interaction for Group X Time, while that for Illness Identity was marginally significant.

There was an overall trend of the odds ratios peaking in the age groups 40–59 and 60–69 years, declining thereafter in the older age groups across all examined outcome categories.

The latter exhibited an increasing trend at T1 (median 0.271μmol/L, IQR 0.062), T2 (0.276 μmol/L, IQR 0.071), and T3 (median 0.272 μmol/L, IQR 0.061) compared to T0 (median 0.235 μmol/L, IQR 0.0815), however without reaching statistical significance. 4.

It was also observed that, although the cases obtained an average score higher in the trait anger/temperament dimension than the controls, this difference was not statistically significant, but it was very near statistical significance.

For smoking-specific experiential avoidance, participants in the ACT group reported a gradual decrease in their AIS scores from baseline to the 12-month follow-up, while participants in the social support group showed a trend of increase.

Nevertheless, results showed clearly significant differences concerning delirium incidence in a propensity score matched cohort.

Furthermore, patients with a greater number of arteries with evidence of CMD showed a trend towards a higher percentage of mid-ventricular + apical pattern and towards a lower percentage of the limited apical pattern.

After adjusting for covariates, factors that significantly increased the odds of an unfavorable outcome at six months ( p < 0.05) in both cohorts were older age, lower GCS score, and higher CT burden (only marginally significant in the full cohort).

Furthermore, subgroup differences after stratification for recruiting centers were also evaluated and found to be marginally non-significant ( p for subgroup differences = 0.07; Figure S11 ).

Similar findings were reported in a meta-analysis of observational studies evaluating the association between early menopause and hypertension matched by age or BMI, with a pooled estimate being marginally significant (OR = 1.13; 95% CI: 1.00; −1.29) [ 6 ].

This study showed a trend of decreasing rSO 2 in the normocapnia group, whereas a trend of increasing rSO 2 in the hypercapnia group.

However, an exploratory subgroup analysis of CPS ≥ 1 with 22C3 antibodies showed a trend toward better use of avelumab (median OS, 14.9 months vs. 11.6 months; HR, 0.72).

However, OR showed an increasing trend as eGFR decreased.

Younger age was borderline significant p = 0.058. 3.2.2.

From a methodological perspective on GWAS analyses, our practical approach is supported by investigations demonstrating nominally significant results occurring significantly less often than expected for low-MAF SNVs, resulting in a conservative bias [ 54 , 55 ].